HealthSpot will unveil new point-of-care lab technology from Samsung that provides analysis from a drop of blood from a finger stick. Pending FDA approval, the device will allow users to obtain easy and accurate blood tests for cholesterol, diabetes and liver tests, as well as other lab tests simultaneously, and get results in as little as 7 minutes. The technology will connect lab results not only with the doctor’s electronic medical record but with the consumer’s personal health record and with the consumer’s insurance benefit plan and billing.

Through HealthSpot’s telehealth platform and integrated biomedical equipment, medical providers can virtually examine a patient using equipment similar to that found in their doctor’s office. With the addition of point-of-care technology, clinicians will be able to get on-demand results to make decisions right at the point of care, providing health systems with efficiency and cost reduction while improving health outcomes.

The integrated lab will allow users to obtain easy and accurate blood tests for cholesterol, diabetes and liver tests, as well as other lab tests simultaneously.The company will use the Samsung LABGEO PT10, a compact clinical chemistry analyzer, that will enable HealthSpot and its partners to provide affordable and on-demand lab results, in addition to access to healthcare providers.

“The addition of blood analysis via Samsung’s smart point-of-care technology will allow providers to go one step further for virtual exams inside the HealthSpot station and serve patients better than ever before,” said HealthSpot CEO Steve Cashman. “We are helping consumerize healthcare – no more needles, no more wait and all at a lower cost. People like that.”

HealthSpot is already bringing the doctor’s office to consumers in retail pharmacies across Ohio. The HealthSpot station is a fully-enclosed, 40-square-foot kiosk enabled with proprietary cloud-based telemedicine software that allows patients to be seen and treated for a series of illnesses and conditions.